Skip to main content
Clinical Trials/NCT01983189
NCT01983189
Terminated
Phase 2

Repetetive Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behavior in Subjects With Autism Spectrum Disorders.

New York State Psychiatric Institute1 site in 1 country10 target enrollmentNovember 2008

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Autism
Sponsor
New York State Psychiatric Institute
Enrollment
10
Locations
1
Primary Endpoint
clinical improvement based on repetitive behavior scale.
Status
Terminated
Last Updated
9 years ago

Overview

Brief Summary

This study is a trial of low frequency Repetitive Transcranial magnetic stimulation( rTMS) for subjects with autism spectrum disorders, specially targeting repetitive behaviors.

Detailed Description

This project is a 3-week double blind cross-over trial for adolescents and adults who meet criteria for autism and have clinically prominent repetitive behaviors. The investigator will apply low frequency rTMS for 20 minutes 5 times a week for 3 weeks targeting the area of brain which was involved in repetitive behaviors. The investigator will obtain clinical measures of repetitive behaviors as well as social functioning pre and post treatment. As a control and a cross-over condition , we will stimulate other area of brain which has nothing to do with repetitive behaviors but may improve social functioning in autism spectrum disorders. In addition to r TMS we will perform a pre and post treatment perfusion functional MRI and obtain TMS measure of excitability of brain.

Registry
clinicaltrials.gov
Start Date
November 2008
End Date
November 2010
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • English Speaking
  • Capacity to give consent and sign HIPAA Authorization
  • Patients currently taking psychotropic medications must be at the same stable dose and likely to be able to continue at the same dose throughout the study
  • ASD diagnosis according to the DSM-IV TR Symptom and Criterion checklist for ASD
  • Significant level of repetitive behaviors to distinguish from movement disorders to be in at least 3 out of 6 sub-scales (stereotyped behavior, self-injurious behavior, compulsive behavior, ritualistic behavior, sameness behavior, restricted behavior) -

Exclusion Criteria

  • Women of child-bearing potential not using birth control, pregnant or breast feeding
  • H/o Bipolar Disorder (lifetime), any Psychotic Disorder (lifetime) history of Major Depressive Disorder or of substance abuse or dependence within the past year
  • Significant sub-average intellectual function (IQ\<70)
  • Intracranial implants
  • Increased risk of seizure for any reason, including prior diagnosis of epilepsy, seizure disorder, febrile seizure, increased intracranial pressure or history of significant head trauma with loss of consciousness for \> 5 minutes.
  • Current significant laboratory abnormality
  • Neurological disorder including but not limited to space occupying brain lesion, any history of seizures, history of cerebrovascular accident, fainting, cerebral aneurysm, dementia, Huntington chorea, Multiple Sclerosis -

Outcomes

Primary Outcomes

clinical improvement based on repetitive behavior scale.

Time Frame: baseline-week3

Secondary Outcomes

  • clinical improvement based on the social responsiveness scale.(before-week3)

Study Sites (1)

Loading locations...

Similar Trials